All.Can welcomes a new member – Pfizer
All.Can International is pleased to announce that Pfizer has recently joined our organisation as a member. Pfizer Inc. is a leading global…
News
Latest news
All.Can Responds to European Parliament Consultations on Rare Diseases and Women’s Health
In early 2025, the European Parliament’s Committee on Public Health (SANT) launched two key public consultations to gather input on rare diseases and women’s health, both now closed. Marking Rare…
Making ‘Early’ Our Mission to Beat Cancer
As an Advisory Group member of Mission Early, All.Can is proud to share recent progress in advancing early cancer care across Europe. Mission Early has published a new op-ed in The…
Upcoming Webinars & Training Course: Driving Efficiency and Awareness Across the Cancer Care Continuum
Do not miss out on two key upcoming webinars and an associated online training course designed to enhance efficiency, data use, and awareness in cancer care across Europe and globally.…
Media coverage
Since All.Can was established, its work has gained coverage in a number of magazines, websites and newspapers.
Read MoreBlog
The All.Can international blog features guest posts from leading figures in cancer care across Europe.
Read moreNewsletter
Explore the All.Can international newsletter archives, dating back to the first issue from March 2017.
Read more